The proposed sale is small relative to the company's ~$8.3B market cap and is partly a mandatory tax-withholding transaction, reducing discretionary signal. Monitor for any acceleration of insider selling or unexpected Form 4 filings from other officers.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Oct 9 $92.61entry
- T+1 · 5w ago −0.63%α −0.57% · $92.03
- T+5 · 5w ago −0.63%α +1.34% · $92.03
- T+20 · 11d ago +11.90%α +17.46% · $103.63
- T+26 · todayOpen
- T+60 · in 7w Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Michael Henry Fiore, former EVP and Chief Compliance Officer of HealthEquity, filed a Form 144 on October 8, 2026, indicating intent to sell 2,032 shares of common stock with an approximate market value of $185,227.59 based on the October 6, 2026 price. The filing also discloses two prior 10b5-1 sales in July 2026 totaling 4,399 shares for $418,074.89, and notes that a portion of the proposed sale is a mandatory 'sell to cover' tax withholding transaction, not a discretionary trade.
Key Facts
- Reporting person: Michael Henry Fiore, former EVP and Chief Compliance Officer
- Proposed sale: 2,032 shares of common stock
- Approximate market value: $185,227.59 (based on $91.13 per share on 10/06/2026)
- Two prior 10b5-1 sales in July 2026: 2,045 shares ($194,444.89) on 07/08 and 2,354 shares ($223,630.00) on 07/10
- Sale is partly mandated by a 'sell to cover' tax withholding obligation under the issuer's equity incentive plan
- Filing date: October 8, 2026
Financial Impact
Proposed sale of 2,032 shares valued at ~$185,228; combined with prior July 10b5-1 sales totals ~$603,303 in planned dispositions over three months
Risk Factors
- Insider selling, even if routine, can signal reduced conviction if it becomes a pattern
- The 10b5-1 plan sales in July suggest pre-planned diversification, not opportunistic selling
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0002016116-26-000022 |
| Document: 0002016116-26-000022-index.html | 0002016116-26-000022 |
| Document: 0002016116-26-000022.txt | 0002016116-26-000022 |
Track record
20 reports on HQY
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 3, 202613d ago Press Release Neutral 2/10 Entry $108.84 Now $104.58 −3.91% settles Dec 3
- Oct 27, 202620d ago Institutional Cluster Neutral 3/10 Entry $100.88 Now $104.58 +3.67% settles Nov 24
- Oct 19, 202628d ago Insider Cluster Neutral 2/10 Entry $96.60 Now $104.58 +8.26% settles Nov 17
- Oct 9, 20265w ago 8-K Neutral 2/10 Entry $92.03 to $102.11 Now $104.58 +13.64% ▲ +10.95% +14.22% vs SPY
- Oct 9, 20265w ago SC 13G/A Neutral 3/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Viewing Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers